Contact Dermatitis
📧 Sign up to get email alerts when something new happens for Contact Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-03-20FDA Approved: CLOBETASOL PROPIONATE — Original Application (Northstar Rx LLC)
FDA approved the original application for a generic clobetasol propionate topical corticosteroid, manufactured by Northstar Rx LLC. The appr…
-
FDA approval · 2017-01-11FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' desoximetasone topical generic under an Original Application (ANDA 208163).
-
FDA approval · 2016-12-13FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)
The FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) from Royal Pharmaceuticals.
-
FDA label_change · 2016-11-02FDA Approved: TRIDESILON CREAM — Supplemental Application (Encore Dermatology Inc)
FDA approved a supplemental application for Tridesilon Cream (desonide 0.05%), updating the product labeling.
-
FDA approval · 2016-10-26FDA Approved: TRIAMCINOLONE ACETONIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA granted approval of a supplemental application for Triamcinolone Acetonide submitted by Sun Pharmaceutical Industries, Inc., resulting i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-05-19FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' fluocinonide acetonide topical product through an original generic application (ANDA).
-
FDA approval · 2016-05-12FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Betamethasone Dipropionate from E. Fougera & Co., authorizing changes to the approved produc…
-
FDA approval · 2016-05-10FDA Approved: DESOXIMETASONE — Original Application (Novel Laboratories, Inc.)
FDA approves a generic topical desoximetasone from Novel Laboratories, Inc. under an Original Application (ANDA 206792).
-
FDA approval · 2016-04-25FDA Approved: FLUOCINOLONE ACETONIDE OIL — Original Application (Rising Pharma Holdings, Inc.)
FDA approves Rising Pharma Holdings' Fluocinonide Acetonide Oil as a generic topical corticosteroid for inflammatory and pruritic skin condi…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy [Phase 3]
Phase 3 clinical trial evaluating safety and efficacy of T.R.U.E. TEST for contact dermatitis has completed.
-
FDA label_change · 2015-06-29FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for clobetasol propionate from Actavis Pharma, Inc. to update the product labeling.
-
FDA label_change · 2015-05-21FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)
The FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Molecular and Cellular Characterization of Spongiotic Dermatitis
A completed clinical trial characterizing the molecular and cellular features of spongiotic dermatitis across multiple inflammatory skin dis…
-
FDA approval · 2015-01-20FDA Approved: BETAMETHASONE VALERATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Betamethasone valerate from E. Fougera & Co., a division of Fougera Pharmaceuticals, LLC. Th…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Exploratory Study of Natural Killer Cells in Human Skin [NA]
Clinical trial update indicates completion of an exploratory study of natural killer cells in human skin, covering Atopic dermatitis, Contac…
-
FDA approval · 2014-07-18FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, updating or expanding its labeling.
-
FDA approval · 2014-07-14FDA Approved: FLUOCINONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's Original Application for fluocinonide, a topical corticosteroid, as a generic product. This marks regulatory cle…
-
FDA approval · 2014-07-14FDA Approved: FLUOCINONIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved an original application for fluocinonide from Sun Pharmaceutical Industries, a topical corticosteroid. The product is indicated…
-
FDA approval · 2014-05-15FDA Approved: TRIDESILON CREAM — Supplemental Application (Encore Dermatology Inc)
FDA approved a supplemental application for TRIDESILON CREAM (desonide 0.05%), indicating a regulatory action related to this dermatology pr…
-
FDA approval · 2014-05-12FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA has approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents [Phase 4]
Phase 4 clinical trial update evaluating T.R.U.E. TEST in children and adolescents with contact dermatitis; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: Bariederm Cream in Chronic Contact Dermatitis [NA]
Clinical trial update for Bariederm Cream in chronic contact dermatitis; the current trial status is unknown.
-
FDA approval · 2013-08-09FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved an original application for a generic fluocinonide acetonide topical product by Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2013-07-23FDA Approved: CORDRAN — Supplemental Application (INA Pharmaceutics, Inc)
FDA approved a supplemental application for Cordran (Flurandrenolide) submitted by INA Pharmaceutics, Inc. The update pertains to changes to…
-
CLINICAL_TRIALS withdrawal · 2013-02-27Clinical Trial Update: Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents [Phase 3]
The Phase 3 clinical evaluation of the T.R.U.E. TEST Panel 3.2 in children and adolescents for contact dermatitis has been withdrawn.